| SPS Home | Contact Us |
  General Information  Registration & Housing   Scientific Programs   Ancillary Presentations   Exhibitors & Sponsors   Awards  


SPS 2010 Sponsors

Diamond
($15,000+)

MPI Research

Emerald
($10,000 to $14,999)

Battelle The Business of Innovation

Pfizer, Inc.

Ruby
($6,000 to $9,999)

Covance

Hoffman-La Roche

Opal
($3,000 to $5,999)

Abbott

Boehringer Ingelheim

Eli Lilly and Company

Lewis B. Kinter &
Terry Timberlake-Kinter

GlaxoSmithKline

Porsolt and Partners Pharmacology

Ricerca Biosciences, LLC

Sapphire
(Up to $2,999)

Aptuit

Calvert Laboratories

emka Technologies

Grunenthal Logo

Wil Research

Xenometrics


General Information

Top 5 Reasons to Attend the SPS Meeting in Boston, Massachusetts September 20–23, 2010!

  1. The SPS Annual Meeting is the most focused scientific meeting targeting the role of safety pharmacology in drug development. Presentations cover a spectrum from theory, to practical experience and specific case studies.
  2. The SPS Annual Meeting is one of the best forums for international "best practice sharing" within the pharmaceutical industry, with contract laboratories and with regulators.
  3. The SPS Annual Meeting offers a comprehensive program of continuing education courses to accommodate both newcomers to the field as well as those with experience in advanced courses.
  4. The SPS Annual Meeting highlights new areas in which safety pharmacology is thought to have an impact in the future to improve drug safety.
  5. The SPS Annual Meeting provides an exciting and fun forum for networking with colleagues as well as a forum for exploring employment opportunities in the area of safety pharmacology.

Additional Reasons to Attend the SPS Meeting

  1. The SPS meeting provides contact with relevant vendors and CROs.
  2. Provides a forum for best practice sharing, bench-marketing, and strategic aspects of safety pharmacology.
  3. State-of-the-art technologies and tests are presented.
  4. Gives insight into the regulatory environment surrounding safety pharmacology.
  5. The meeting provides special emphasis onpreclinical cardiovascular and electrophysiological profiling of development compounds and bridging to clinical studies.
  6. CE offerings includes comprehensive introduction to safety pharmacology as well as advanced topics such as drug abuse liability (a challenge for even the experienced Safety Pharmacologist).
  7. Membership of SPS enables discounted registration or reduced admission at SPS meetings or novel themed workshops and allows for attendees to provide feedback to the organizing committees about topic content quality.
  8. The SPS Annual Meeting rotates between key local venues across the North America (even years) and convenient European locations (odd years).
  9. The Distinguished Scientist Award, and the Student and Jr. Scientist Travel Award winners are announced at the scientific Annual Meeting and Awards session.
  10. The SPS Annual Meeting focuses on key issues of contemporary human pharmaceutical safety, by exploring how clinical adverse events arise and whether these were predicted by the nonclinical testing in nonrodent species.
  11. The SPS Annual Meeting offers value-for-money pragmatic guidance from local experts or those of our organizers who have visited the area in advance of the Meeting. 

 

Payments & Deadlines Information

Poster Presentation Guidelines

SPS Travel Safety Tips

Theft While in Travel Status

 

 

Copyright 2010. All Rights Reserved.

Safety Pharmacology Society | 1821 Michael Faraday Drive, Suite 300 | Reston, VA 20190 | U.S.A.
Fax: (703) 438-3113 | E-mail: SPS Headquarters

Voice:  (703) 547-0874